Metformin: an update. Ann Intern Med 137:25–33, 2002 11. Nathan DM: Initial management of glyce- mia in type 2 diabetes mellitus. N Engl J Med 347:1342–1349, 2002 12. Riddle MC, Rosenstock J, Gerich J: The Treat-to-Target Trial: randomized addi-tion of glargine or human NPH insulin tooral therapy of type 2 diabetic patients.Diabetes Care 26:3080–3086, 2003 13. Dailey GE, Noor MA, Park JS, Bruce S,Fiedorek FT: Glycemic control with gly-buride/metformin tablets in combinationwith rosiglitazone in patients with type 2diabetes: a randomized, double-blind trial.Am J Med 116:223–229, 2004 14. Drucker DJ: Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26:2929–2940, 2003 15. Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K,Kim D, Aisporna M, Wang Y, Baron AD:Synthetic exendin-4 (exenatide) signiﬁ-cantly reduces postprandial and fastingplasma glucose in subjects with type 2 di-abetes. J Clin Endocrinol Metab 88:3082– 3089, 2003